Wuhan EasyDiagnosis Biomedicine Co., Ltd.
(Stock code: 002932.SZ)
EasyDiagnosis, founded in 2008, is a leading developer, manufacturer, and marketer of In-Vitro Diagnostic (IVD) products. We offer In-Vitro Diagnostics reagents and instruments in fields of Blood Gas Analysis, Immunodiagnosis, Molecular Diagnosis, Coagulation Analysis, covering POCT and critical care solutions. At EasyDiagnosis, we strive to be at the forefront of medical technology, providing medical professionals with the tools they need to deliver accurate and efficient diagnoses. Our products are distributed to over 7,500 medical facilities in more than 100 countries worldwide. With our advanced products and excellent customer service, we are confident in contributing to the advancement of healthcare worldwide.
+
Patents
+
R&D engineers
+㎡
Factory
$1.5bill.
Revenue in 2022
+
Countries and regions
+
Medical facilities
Blood Gas Analysis
EasyDiagnosis provides blood gas solutions that guarantee confidence with every test. Our solutions are designed to accurately measure oxygen and carbon dioxide levels in human blood as well blood's pH balance.Learn more
ImmunoDiagnosis
EasyDiagnosis’s immunoassay solutions provide confidence to labs of any size. By utilizing advanced technology and exceptional designs, EasyDiagnosis’s solutions provide accurate and reliable results for a variety of tests.Learn more
Molecular Diagnosis
EasyDiagnosis's molecular solutions use advanced PCR and sequencing techniques for precise quantification and sensitive detection of various pathogens, including viruses, bacteria, and fungi, causing major infectious diseases.Learn more
Coagulation Analysis
EasyDiagnosis's coagulation solutions offer fast, reliable, and accurate results in various healthcare scenarios. It helps physicians in evaluating the probability of excessive bleeding or thrombosis in human blood vessels.Learn more
1.jpg)
